DNAVision helps pharmaceutical companies and clinical research organizations effectively integrate pharmacogenetics into their drug development program and thus deliver safer, more effective products to the market more quickly.
Identify and evaluate polymorphisms in drug metabolizing enzymes, transporters, or targets relevant to anticancer agents. Includes publications, training, and related links.
Provides an easily understandable introduction to pharmacogenomics, the study of how different drugs interact with multiple genes and the biological molecules they encode.